Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

GLS-5700 DNA Vaccine for Prevention of Infection from Zika Virus

Drug (Brand / Generic)

GLS-5700 DNA vaccine

Therapy Class

Synthetic DNA plasmid vaccine

Current Indication

Zika virus infection

Market Sector

Anti-infective

Development Status

Phase I clinical trials in progress

Developers

Inovio Pharmaceuticals and GeneOne Life Sciences
Expand

Go Top